Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-03-03 @ 6:15 AM
Study NCT ID:
NCT02185820
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2014-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD)
Sponsor:
European Myeloma Network B.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06
Start Date Type:
ACTUAL
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-07
First Submit QC Date:
None
Study First Post Date:
2014-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-29
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL